Boundless Bio Files Q1 2025 10-Q
Ticker: BOLD · Form: 10-Q · Filed: May 9, 2025 · CIK: 1782303
| Field | Detail |
|---|---|
| Company | Boundless Bio, INC. (BOLD) |
| Form Type | 10-Q |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Boundless Bio's Q1 2025 10-Q is in. Check financials and stock info.
AI Summary
Boundless Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial position and results of operations. Key financial data points include cash equivalents and short-term investments as of December 31, 2024, and common stock information. The filing also references subsequent events and various stock-related plans and agreements.
Why It Matters
This filing provides investors with an update on Boundless Bio's financial health and operational status for the first quarter of 2025, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the nature of the pharmaceutical industry and the company's stage of development can introduce inherent risks.
Key Numbers
- 2024-12-31 — Reporting Date (Key dates for financial statement balances)
- 2025-03-31 — Reporting Date (Key dates for financial statement balances)
Key Players & Entities
- Boundless Bio, Inc. (company) — Filer of the 10-Q
- 0000950170-25-067496 (other) — Accession Number for the filing
- 20250331 (date) — Period of report
- 20250509 (date) — Filing date
- 001-41989 (other) — SEC File Number
- TwoThousandTwentyFourIncentiveAwardPlanMember (other) — Mentioned stock plan
- OpenMarketSaleAgreementMember (other) — Mentioned agreement
FAQ
What is the total amount of cash and cash equivalents reported as of December 31, 2024?
The filing indicates 'us-gaap:CashEquivalentsMember' as of '2024-12-31', but the specific dollar amount is not provided in this excerpt.
What is the filing date for this 10-Q report?
The filing date is 20250509.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending 20250331.
What is the SEC file number for Boundless Bio, Inc.?
The SEC file number for Boundless Bio, Inc. is 001-41989.
Are there any subsequent events mentioned in the filing?
Yes, the filing references 'us-gaap:SubsequentEventMember' and 'OpenMarketSaleAgreementMember' with dates of 2025-04-01.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding Boundless Bio, Inc. (BOLD).